Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco

Nicotine and Tobacco Research

Volumn 21, Issue 9, 2019, Pages 1228-1238

  Lorkiewicz, Pawel ^a   Riggs, Daniel W ^a   Keith, Rachel J ^a   Conklin, Daniel J ^a   Xie, Zhengzhi ^a   Sutaria, Saurin ^a   Lynch, Blake ^a   Srivastava, Sanjay ^a   Bhatnagar, Aruni ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NICOTINE; VOLATILE ORGANIC COMPOUND;

ADULT; CIGARETTE SMOKING; COMPARATIVE STUDY; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; SMOKELESS TOBACCO; TOBACCO; TOBACCO USE; URINE; VAPING; YOUNG ADULT;

ADULT; BIOMARKERS; CIGARETTE SMOKING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; TOBACCO PRODUCTS; TOBACCO USE; TOBACCO, SMOKELESS; VAPING; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 85059477062     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty089     Document Type: Article

References (48)

1. U.S. Department of Health and Human Services. 2014 Surgeon General?s Report: The Health Consequences of Smoking?50 Years of Progress. 2014.
2. Youth E-CUA, Health UDo, Services H. A Report of the Surgeon General? Executive Summary. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016.
3. Wackowski OA, Bover Manderski MT, Delnevo CD. Comparison of direct and indirect measures of E-cigarette risk perceptions. Tob Regul Sci. 2016;2(1):38?43.
4. Amrock SM, Lee L, Weitzman M. Perceptions of e-Cigarettes and noncigarette tobacco products among US youth. Pediatrics. 2016;138(5). pii:e20154306.
5. Etter JF, Bullen C. Electronic cigarette: Users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106(11):2017?2028.
6. Camenga DR, Kong G, Cavallo DA, Krishnan-Sarin S. Current and former smokers? use of electronic cigarettes for quitting smoking: An exploratory study of adolescents and young adults. Nicotine Tob Res. 2017;19(12):1531?1535.
7. Baeza-Loya S, Viswanath H, Carter A, et al. Perceptions about e-cigarette safety may lead to e-smoking during pregnancy. Bull Menninger Clin. 2014;78(3):243?252.
8. Ashford K, Wiggins A, Butler K, Ickes M, Rayens MK, Hahn E. e-Cigarette use and perceived harm among women of childbearing age who reported tobacco use during the past year. Nurs Res. 2016;65(5):408?414.
9. Liu G, Wasserman E, Kong L, Foulds J. A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study. Prev Med. 2017;104:86?91.
10. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control. 2017;26(e1):e23?e28.
11. Ramôa CP, Hiler MM, Spindle TR, et al. Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: A preliminary report. Tob Control. 2016;25(e1):e6?e9.
12. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;(suppl 2):ii11?17.
13. Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248?260.
14. Bansal V, Kim K-H. Review on quantitation methods for hazardous pollutants released by e-cigarette (EC) smoking. TRAC Trends Anal Chem 2016;78:120?133.
15. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133?139.
16. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319?1326.
17. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol. 2014;88(7):1295?1308.
18. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol. 2012;25(4):794?810.
19. Bhatnagar A. E-Cigarettes and cardiovascular disease risk: Evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep. 2016;10(7):24.
20. McGwin G, Lienert J, Kennedy JI. Formaldehyde exposure and asthma in children: A systematic review. Environ Health Perspect. 2010;118(3):313?317.
21. Sakula A. Formalin asthma in hospital laboratory staff. Lancet. 1975;2(7939):816.
22. DeJarnett N, Conklin DJ, Riggs DW, et al. Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc. 2014;3(4). pii:e000934.
23. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2015;17(6):704?709.
24. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P 3rd, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: A longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160?167.
25. McRobbie H, Phillips A, Goniewicz ML, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila). 2015;8(9):873?878.
26. Benowitz NL, Hukkanen J, Jacob P, 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009(192):29?60.
27. Gregg EO, Minet E, McEwan M. Urinary biomarkers of smokers? exposure to tobacco smoke constituents in tobacco products assessment: A fit for purpose approach. Biomarkers. 2013;18(6):467?486.
28. Theophilus EH, Coggins CR, Chen P, Schmidt E, Borgerding MF. Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: A one-week clinical confinement study. Regul Toxicol Pharmacol. 2015;71(2):225?234.
29. van Welie RT, van Dijck RG, Vermeulen NP, van Sittert NJ. Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol. 1992;22(5-6):271?306.
30. Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta. 2012;750:152?160.
31. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-Term E-Cigarette and nicotine replacement therapy users: A cross-sectional study. Ann Intern Med 2017;66(6):390?400
32. Scherer G, Urban M, Engl J, Hagedorn HW, Riedel K. Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal Toxicol. 2006;18(10):821?829.
33. Sarkar M, Kapur S, Frost-Pineda K, et al. Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-Term and long-Term clinical studies. Nicotine Tob Res. 2008;10(12):1761?1772.
34. Carmella SG, Chen M, Han S, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2009;22(4):734?741.
35. Tayyarah R, Long GA. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Regul Toxicol Pharmacol. 2014;70(3):704?710.
36. Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: A review. Int J Toxicol. 2016;35(2):179?185.
37. St Helen G, Havel C, Dempsey DA, Jacob P 3rd, Benowitz NL. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016;111(3):535?544.
38. Counts ME, Morton MJ, Laffoon SW, Cox RH, Lipowicz PJ. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol. 2005;41(3):185?227.
39. Henning RJ, Johnson GT, Coyle JP, Harbison RD. Acrolein can cause cardiovascular disease: A review. Cardiovasc Toxicol. 2017;17(3):227?236
40. Brajenovic N, Karaconji IB, Bulog A. Evaluation of urinary btex, Nicotine, and cotinine as biomarkers of airborne pollutants in nonsmokers and smokers. J Toxicol Environ Health A. 2015;78(17):1133?1136.
41. Pankow JF, Kim K, McWhirter KJ, et al. Benzene formation in electronic cigarettes. PLoS One. 2017;12(3):e0173055.
42. Gordon SM, Brinkman MC, Meng RQ, et al. Effect of cigarette menthol content on mainstream smoke emissions. Chem Res Toxicol. 2011;24(10):1744?1753.
43. Niaz K, Bahadar H, Maqbool F, Abdollahi M. A review of environmental and occupational exposure to xylene and its health concerns. EXCLI J. 2015;14:1167?1186.
44. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-Term E-Cigarette and nicotine replacement therapy users: A cross-sectional study. Ann Intern Med. 2017;166(6): 390?400.
45. Burns DM, Dybing E, Gray N, et al. Mandated lowering of toxicants in cigarette smoke: A description of the world health organization TobReg proposal. Tob Control. 2008;17(2):132?141.
46. Food U, Administration D. Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904 (a)(3) of the Federal Food, Drug, and Cosmetic Act. Rockville, MD: US Department of Health and Human Services. Food and Drug Administration, Center for Tobacco Products; 2012.
47. FDA Center for Tobacco Products Research Interest Areas. https://prevention. nih.gov/tobacco-regulatory-science-program/research-priorities Accessed on May 28, 2018.
48. Gillman IG, Kistler KA, Stewart EW, Paolantonio AR. Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols. Regul Toxicol Pharmacol. 2016;75:58?65